Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease.
作者信息
Gamage Kanchana K, Kumar Sushanth
机构信息
Department of Biology and
Department of Biology and.
出版信息
J Neurosci. 2017 Apr 26;37(17):4430-4432. doi: 10.1523/JNEUROSCI.0420-17.2017.
Abstract
摘要
相似文献
1
Aducanumab Therapy Ameliorates Calcium Overload in a Mouse Model of Alzheimer's Disease.
J Neurosci. 2017 Apr 26;37(17):4430-4432. doi: 10.1523/JNEUROSCI.0420-17.2017.
2
Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice.
J Neurosci. 2016 Dec 14;36(50):12549-12558. doi: 10.1523/JNEUROSCI.2080-16.2016. Epub 2016 Nov 3.
3
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Nature. 2016 Sep 1;537(7618):50-6. doi: 10.1038/nature19323.
4
Biogen's aducanumab raises hope that Alzheimer's can be treated at its source.
Manag Care. 2015 Jun;24(6):19.
5
Aducanumab: The first targeted Alzheimer's therapy.
Drug Discov Ther. 2021;15(3):166-168. doi: 10.5582/ddt.2021.01061.
6
Solanezumab and the amyloid hypothesis for Alzheimer's disease.
BMJ. 2016 Dec 29;355:i6771. doi: 10.1136/bmj.i6771.
7
Controversy and Progress in Alzheimer's Disease - FDA Approval of Aducanumab.
N Engl J Med. 2021 Aug 26;385(9):771-774. doi: 10.1056/NEJMp2111320. Epub 2021 Jul 28.
8
Aducanumab: look before leaping.
Nat Med. 2021 Sep;27(9):1499. doi: 10.1038/s41591-021-01477-5.
9
Why aducanumab is important.
Nat Med. 2021 Sep;27(9):1498. doi: 10.1038/s41591-021-01478-4.
10
Revisiting FDA Approval of Aducanumab.
N Engl J Med. 2021 Aug 26;385(9):769-771. doi: 10.1056/NEJMp2110468. Epub 2021 Jul 28.
引用本文的文献
1
Aducanumab in Alzheimer's Disease: A Critical Update.
Curr Med Chem. 2024;31(31):5004-5026. doi: 10.2174/0929867331666230727103553.
2
Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective.
Sci China Life Sci. 2023 Dec;66(12):2711-2754. doi: 10.1007/s11427-022-2357-x. Epub 2023 Jul 17.
3
Aducanumab, a Novel Anti-Amyloid Monoclonal Antibody, for the Treatment of Alzheimer's Disease: A Comprehensive Review.
Health Psychol Res. 2022 Jan 30;10(1):31925. doi: 10.52965/001c.31925. eCollection 2022.
4
Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive review.
Health Psychol Res. 2022 Jul 28;10(3):37023. doi: 10.52965/001c.37023. eCollection 2022.
5
Synthesis and Biological Assessment of 4,1-Benzothiazepines with Neuroprotective Activity on the Ca Overload for the Treatment of Neurodegenerative Diseases and Stroke.
Molecules. 2021 Jul 24;26(15):4473. doi: 10.3390/molecules26154473.
6
Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives.
Sci China Life Sci. 2021 Jun;64(6):926-937. doi: 10.1007/s11427-020-1810-y. Epub 2020 Oct 23.
7
Pharmacotherapy of Alzheimer's Disease: Seeking Clarity in a Time of Uncertainty.
Front Pharmacol. 2020 Mar 24;11:261. doi: 10.3389/fphar.2020.00261. eCollection 2020.
8
Drug Development for Alzheimer's Disease: Microglia Induced Neuroinflammation as a Target?
Int J Mol Sci. 2019 Jan 28;20(3):558. doi: 10.3390/ijms20030558.
本文引用的文献
1
Failed Alzheimer's trial does not kill leading theory of disease.
Nature. 2016 Nov 23;540(7631):15-16. doi: 10.1038/nature.2016.21045.
2
Immunotherapy with Aducanumab Restores Calcium Homeostasis in Tg2576 Mice.
J Neurosci. 2016 Dec 14;36(50):12549-12558. doi: 10.1523/JNEUROSCI.2080-16.2016. Epub 2016 Nov 3.
3
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.
Nature. 2016 Sep 1;537(7618):50-6. doi: 10.1038/nature19323.
4
Immunotherapeutic approaches for Alzheimer's disease.
Neuron. 2015 Mar 18;85(6):1162-76. doi: 10.1016/j.neuron.2014.12.064.
5
Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics.
Alzheimers Res Ther. 2014 Jul 9;6(4):42. doi: 10.1186/alzrt272. eCollection 2014.
6
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.
7
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.
N Engl J Med. 2014 Jan 23;370(4):311-21. doi: 10.1056/NEJMoa1312889.
8
Calcium regulation of neural rhythms, memory and Alzheimer's disease.
J Physiol. 2014 Jan 15;592(2):281-93. doi: 10.1113/jphysiol.2013.257527. Epub 2013 Jun 10.
9
Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer's disease.
Neurotox Res. 2013 Oct;24(3):358-69. doi: 10.1007/s12640-013-9398-z. Epub 2013 May 9.
10
A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.
Neuron. 2012 Dec 6;76(5):908-20. doi: 10.1016/j.neuron.2012.10.029.
Zotero 插件